About Us
Holool Pharma (Part of Al-Bilad Solutions Holding) is a leading emerging company specialized primarily in pharmaceutical products marketing and manufacturing in particular in advanced therapeutic areas that represent challenges in global disease burden.
Holool Pharma (Part of Al-Bilad Solutions Holding) is a leading emerging company specialized primarily in pharmaceutical products marketing and manufacturing in particular in advanced therapeutic areas that represent challenges in global disease burden.
See MoreOur Mission
is to build an organization that promote professional growth , to facilitate the reach of our services to the community in KSA through Cutting –Edge technologies and products.
Our Values
relies on our exceptional team coming from diversifies experiences and cosmopolitan culture but more and above our successful network of partners and business associates within the borders of Saudi Arabia and Globally.
Our Vision
is to be among the leading service providers in Saudi Arabia and the Middle East , strengthen and facilitate strategic alliance for manufacturing and marketing of innovative pharmaceuticals and other innovative medical brands inline with Vision 2030 for Kingdom of Saudi Arabia to be the leading regional center of excellence for advanced industries in MENA region.
17,000
Cubic meters of radioactive waste treated at ICPE for safe storage at ANDRA
4,000
Cubic meters of annual radioactive waste treatment capacity.
10,000
Radioactive nuclear transportation shipments of all categories performed.
Dr. Mohammed Hussein
Executive General Manager
Executive General Manager Message
The year of 2024 marks the beginning of a new journey for us , in a global landscape characterized by increasing diversity, division, and geopolitical risk, coupled with financial markets volatility, the business environment is fraught with unprecedented uncertainty.
In response to these challenges, we recognize the need for a dynamic and multi-faceted strategy to effectively navigate the future. Where we are living in a vibrant society we became more resilient to position our corporate among the leading players in Middle East Region providing exceptional products and services to our community and stakeholders
In pharmaceuticals and healthcare products, our commitment is unwavering. We are deeply involved in marketing , manufacturing , licensing agreements, and strategic partnership. Our focus spans a range of medical concerns, including life threatening disease of cancer and genetic disorders, while embracing new modalities and the transformative potential of digital technology.
Your trust and partnership are invaluable as we strive to achieve our shared goals. We sincerely ask for your continued understanding and support as we embark on this exciting new chapter.
